Ever Fortune.AI Co., Ltd. (TPEX:6841)
Taiwan · Delayed Price · Currency is TWD 56.40
+0.10 (0.18%)
Jun 3, 2026, 1:30 PM CST
Ever Fortune.AI Revenue
Ever Fortune.AI had revenue of 69.45M TWD in the quarter ending March 31, 2026, a decrease of -3.61%. This brings the company's revenue in the last twelve months to 376.20M, up 6.07% year-over-year. In the year 2025, Ever Fortune.AI had annual revenue of 378.81M with 12.23% growth.
Revenue (ttm)
376.20M
Revenue Growth
+6.07%
P/S Ratio
14.16
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 378.81M | 41.29M | 12.23% |
| Dec 31, 2024 | 337.52M | 243.54M | 259.13% |
| Dec 31, 2023 | 93.98M | 40.08M | 74.35% |
| Dec 31, 2022 | 53.90M | 15.66M | 40.94% |
| Dec 31, 2021 | 38.24M | 34.76M | 996.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 24.42B |
| PharmaEssentia | 17.50B |
| CHC Healthcare Group | 4.55B |
| Panion & Bf Biotech | 2.10B |
| Orient Pharma | 1.41B |
| LIWANLI Innovation | 243.15M |
| ACRO Biomedical | 38.26M |
| Caliway Biopharmaceuticals | 38.04M |